SAS code for 3-period, partial-replicated crossover study [RSABE / ABEL]

posted by scorp2011 – India, 2015-06-15 14:36 (3615 d 17:00 ago) – Posting: # 14957
Views: 8,320

We have two Test formulations (T1 and T2) and One single Reference formulation (R). We want to test for bioequivalence of each test formulation against the reference formulation i.e. T1 vs. R and T2 vs. R. The test drug is a candidate of "NTI" Please suggest me the whether we can analyze the study as per the SAS code (after adequately modifying the same) provided by the USFDA in Warfarin OGD guidance.
Regards
Sonu

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
148 visitors (0 registered, 148 guests [including 3 identified bots]).
Forum time: 07:36 CEST (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5